LEXINGTON, Mass., Sept. 26, 2019 /PRNewswire/ -- Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development of innovative therapeutics for the treatment of cancer, today announced that James Dentzer, Chief Executive Officer of Curis, will present at the Cantor Fitzgerald Global Healthcare Conference on Thursday, October 3, 2019 at

SMITHS FALLS, ON and MONTREAL, Sept. 26, 2019 /PRNewswire/ - Spectrum Therapeutics ("Spectrum"), the medical division of Canopy Growth Corporation (TSX: WEED) (NYSE: CGC) is pleased to announce a donation to the Fondation de l'Hôpital du Sacré-Coeur de Montreal (Montreal Sacre Coeur Hospital Foundation) to supp

TEL AVIV, Israel, Sept. 26, 2019 /PRNewswire/ -- Galmed Pharmaceuticals Ltd. (Nasdaq: GLMD) ("Galmed" or the "Company"), a clinical-stage biopharmaceutical company focused on the development of the liver targeted SCD1 modulator Aramchol, an oral therapy for the treatment of nonalcoholic steatohepatitis ("NASH") and fibrosis, announced today the initiation of its Phase 3/

SAN DIEGO and PENNINGTON, N.J., Sept. 26, 2019 /PRNewswire/ -- OncoSec Medical Incorporated (OncoSec) (NASDAQ: ONCS), a company developing late-stage intratumoral cancer immunotherapies, today announced that Daniel J. O'Connor, President and Chief Executive Officer of OncoSec, will present a company ove

TORRANCE, Calif., Sept. 26, 2019 /PRNewswire/ -- Emmaus Life Sciences, Inc. (OTCQB: EMMA), a leader in sickle cell disease treatment, today announced it is approved to have its common stock trade on the OTCQB marketplace, effective September 26, 2019. The common stock of Emmaus was previously quoted on OTC Link® as OTC P

NEW YORK, Sept. 26, 2019 /PRNewswire/ -- Hospital for Special Surgery (HSS), the top-ranked orthopedic hospital in the nation, today announced the appointments of Harvinder S. Sandhu, MD, MBA, and Andrew A. Sama, MD, as the new co-chiefs of its spine service, effective October 2019

DULUTH, Ga., Sept. 26, 2019 /PRNewswire/ -- Boehringer Ingelheim, a global leader in veterinary rabies vaccines2, plans to donate 60,000 doses of its IMRAB® rabies vaccine for dogs over the next three years to fight rabies in Puerto Rico.

DODGEVILLE, Wisc., Sept. 26, 2019 /PRNewswire/ -- Lands' End (NASDAQ: LE), the iconic American heritage brand, has launched a new line of scrubs to service the healthcare industry. The line was developed by Lands' End Business, a division of Lands' End specializing in an extensive range of business uniforms, workwear and promotional items, with the unique ability to

MINNEAPOLIS, Sept. 26, 2019 /PRNewswire/ -- Nura announced today that it will begin providing free Narcan® kits and training directly to select patients who take opiat

ABBOTT PARK, Ill., Sept. 26, 2019 /PRNewswire/ -- Abbott (NYSE: ABT) today announced the U.S. Food and Drug Administration (FDA) has approved the company's Proclaim XR™ recharge-free neurostimulation system for people living with chronic pain. The Proclaim XR platform offers a low dose of Abbott's proprietary BurstDR™ stimulation waveform, which was created based on sc